Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs

Vaccine

Volumn 32, Issue 21, 2014, Pages 2480-2486

  Seo, Hwi Won ^a   Park, Su Jin ^a   Park, Changhoon ^a   Chae, Chanhee ^a  

^a Seoul National University   (South Korea)

Author keywords

Mycoplasma hyopneumoniae; Porcine circovirus type 2; Porcine circovirus associated disease; Porcine respiratory disease complex; Vaccine

Indexed keywords

BACTERIAL DNA; BACTERIAL VACCINE; GAMMA INTERFERON; MYCOPLASMA HYOPNEUMONIAE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ARTICLE; CIRCOVIRUS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; HISTOPATHOLOGY; LUNG LESION; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; NOSE SMEAR; PORCINE CIRCOVIRUS TYPE 2; PRIORITY JOURNAL; SWINE; VACCINATION; VIREMIA;

MYCOPLASMA HYOPNEUMONIAE; PORCINE CIRCOVIRUS TYPE 2; PORCINE CIRCOVIRUS-ASSOCIATED DISEASE; PORCINE RESPIRATORY DISEASE COMPLEX; VACCINE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BACTERIAL SHEDDING; BACTERIAL VACCINES; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; COINFECTION; DNA, BACTERIAL; DNA, VIRAL; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LUNG; MYCOPLASMA HYOPNEUMONIAE; PNEUMONIA OF SWINE, MYCOPLASMAL; SUS SCROFA; SWINE; VIRAL VACCINES; VIREMIA;

EID: 84898492086     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.088     Document Type: Article

References (34)

1. Chae C. Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. Vet J 2004, 168:41-49.
2. Simionatto S., Marchioro S.B., Maes D., Dellagostin O.A. Mycoplasma hyopneumoniae: From disease to vaccine development. Vet Microbiol 2013, 165:234-242.
3. Kim J., Chung H.K., Chae C. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet J 2003, 166:251-256.
4. Opriessnig T., Thacker E.L., Yu S., Fenaux M., Meng X-J., Halbur P.G. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol 2004, 41:624-640.
5. Sibila M., Fort M., Nofrarias M., Perez de Rozas A., Galindo-Cardiel I., Mateu E., et al. Simultaneous porcine circovirus type 2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs. J Comp Pathol 2012, 147:285-295.
6. Zhang H., Lunney J.K., Baker R.B., Opriessnig T. Cytokine and chemokine mRNA expression profiles in tracheobronchial lymph nodes from pigs singularly infected or coinfected with porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae (MHYO). Vet Immunol Immunopathol 2011, 140:152-158.
7. Allan G.M., McNeilly F., McNair I., O'Connor M., Meehan B., Gilpin D., et al. Neonatal vaccination for Mycoplasma hyopneumoniae and post-weaning multisystemic wasting syndrome: a field trial. Pig J 2001, 48:34-41.
8. Kyriakis S.C., Saoulidis K., Lekkas S., Miliotis C.C., Papoutsis P.A., Kennedy S. The effect of immune-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome. J Comp Pathol 2002, 126:38-46.
9. Gagnon C.A., del Castillo J.R., Music N., Fontaine G., Harel J., Tremblay D. Development and use of a multiplex real-time quantitative polymerase chain reaction assay for detection and differentiation of Porcine circovirus-2 genotypes 2a and 2b in an epidemiological survey. J Vet Diagn Invest 2008, 20:545-558.
10. Wasilk A., Callahan J.D., Christopher-Hennings J., Gay T.A., Fang Y., Dammen M., et al. Detection of U.S., Lelystad, and European-like porcine reproductive and respiratory syndrome viruses and relative quantitation in boar semen and serum samples by real-time PCR. J Clin Microbiol 2004, 42:4453-4461.
11. Dubosson C.R., Conzelmann C., Miserez R., Boerlin P., Frey J., Zimmermann W., et al. Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Vet Microbiol 2004, 102:55-65.
12. Kim D., Kim C.H., Han K., Seo H.W., Oh Y., Park C., et al. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M, hyopneumoniae and PCV2. Vaccine 2011, 29:3206-3212.
13. Beaver B.V., Reed W., Leary S., McKiernan B., Bain F., Schultz R., et al. 2000 report of the AVMA panel on euthanasia. J Am Vet Med Assoc 2001, 218:669-696.
14. Pogranichnyy R.M., Yoon K.J., Harms P.A., Swenson S.L., Zimmerman J.J., Sorden S.D. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol 2000, 13:143-153.
15. Park C., Oh Y., Seo H.W., Han K., Chae C. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model. Clin Vaccine Immunol 2013, 20:369-376.
16. Bandrick M., Pieters M., Pijoan C., Molitor T.W. Passive transfer of maternal Mycoplasma hyopneumoniae-specific cellular immunity to piglet. Clin Vaccine Immunol 2008, 15:540-543.
17. Diaz I., Mateu E. Use of ELISPOT and ELISA to evaluate IFN-γ, IL-10 and IL-4 responses in conventional pigs. Vet Immunol Immunopathol 2005, 106:107-112.
18. Thacker E.L., Thacker B.J., Kuhn M., Hawkins P.A., Waters W.R. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am J Vet Res 2000, 61:1384-1389.
19. Kwon D., Chae C. Detection and localization of Mycoplasma hyopneumoniae DNA in lungs from naturally infected pigs by in situ hybridization using a digoxigenin-labeled probe. Vet Pathol 1999, 36:308-313.
20. Kim J., Choi C., Chae C. Pathogenesis of postweaning multisystemic wasting syndrome reproduced by co-infection with Korean isolates of porcine circovirus 2 and porcine parvovirus. J Comp Pathol 2003, 128:52-59.
21. Straw B.E., Backstrom L., Leman A.D. Examination of swine at slaughter Part II. Findings at slaughter and their significance. Compend Contin Educ Pract Vet 1986, 8:S106-S122.
22. Kim J., Chae C. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation. J Comp Pathol 2004, 131:121-126.
23. Meerts P., van Gucht S., Cox E., Vandebosch A., Nauwynck H.J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 2005, 18:333-341.
24. Meerts P., Misinzo G., Lefebvre D., Nielsen J., Botner A., Kristensen C.S., et al. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2006, 2:6-16.
25. Liu Q., Wang L., Willson P., Babiuk L.A. Quantitative, competitive PCR analysis of porcine circovirus DNA in serum from pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol 2000, 38:3474-3477.
26. Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. J Virol Methods 2004, 117:75-80.
27. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
28. Fort M., Fernandes L.T., Nofrarias M., Diaz I., Sibila M., Pujols J., et al. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet Immunol Immunopathol 2009, 129:101-107.
29. Seo H.W., Han K., Oh Y., Park C., Chae C. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions. Vaccine 2012, 30:6671-6677.
30. Chae C. Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application. Vet J 2012, 194:151-157.
31. Rodriguez F., Ramirez G.A., Sarradell J., Andrada M., Lorenzo H. Immunohistochemical labeling of cytokines in lung lesions of pigs naturally infected with Mycoplasma hyopneumoniae. J Comp Pathol 2004, 130:306-312.
32. Mateusen B., Maes D., Van Goubergen M., Verdonck M., de Kruif A. Effectiveness of treatment with linocomycin hydrochloride and/or vaccination against Mycoplasma hyopneumoniae for controlling chronic respiratory disease in a herd of pigs. Vet Rec 2002, 151:135-140.
33. Djordjevic S.P., Eamens G.J., Romalis L.F., Nicholls P.J., Taylor V., Chin J. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust Vet J 1997, 75:504-511.
34. Kekarainen T., Montoya M., Mateu E., Segalés J. Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses. J Gen Virol 2008, 89:760-765.